zDHHC3-mediated S-palmitoylation of SLC9A2 regulates apoptosis in kidney clear cell carcinoma
Related Experiment Video
Updated: Jun 28, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Xiuyun Zhang1, Junpeng Hou2, Guangyuan Zhou3
1Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, 430000, China.
Purpose:
Kidney clear cell carcinoma (KIRC) has a poor prognosis, high morbidity and mortality rates, and high invasion and metastasis rate, and effective therapeutic targets are lacking. zDHHC3 has been implicated in various cancers, but its specific role in KIRC remains unclear.
Methods:
In this study, we performed a pan-cancer analysis, bioinformatics analysis, and cell experiment to detect the role of zDHHC3 in KIRC.
Results:
zDHHC3 was significantly down-regulated in KIRC, and that its high expression was associated with favorable patient outcomes. We identified 202 hub genes that were most relevant to high zDHHC3 expression and KIRC, and found that they were involved mainly in ion transport and renal cell carcinoma. Among these hub genes, SLC9A2 was identified as a downstream gene of zDHHC3. zDHHC3 suppression led to decreased expression and S-palmitoylation of SLC9A2, which further inhibited the apoptosis of Caki-2 cells.
Conclusion:
Our findings suggest that zDHHC3 plays an important role in KIRC, due partly to its regulation of SLC9A2 S-palmitoylation. The targeting of the zDHHC3-SLC9A2 axis may provide a new option for the clinical treatment of KIRC.
Insights
zDHHC3 is down-regulated in kidney clear cell carcinoma (KIRC), and its targeting may offer new therapeutic options. This study reveals zDHHC3 regulates SLC9A2 S-palmitoylation, impacting KIRC progression.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Kidney clear cell carcinoma (KIRC) presents significant challenges due to poor prognosis and limited therapeutic targets.
- The role of zDHHC3, implicated in other cancers, is not well-defined in KIRC.
Purpose of the Study:
- To investigate the role and mechanism of zDHHC3 in kidney clear cell carcinoma.
- To identify potential therapeutic targets within the zDHHC3 pathway in KIRC.
Main Methods:
- Pan-cancer analysis and bioinformatics approaches were employed.
- Cell experiments were conducted to validate findings in KIRC models.
- Hub genes associated with zDHHC3 expression in KIRC were identified.
Main Results:
- zDHHC3 expression was significantly downregulated in KIRC, correlating with better patient outcomes.
- A network of 202 hub genes linked to zDHHC3 expression in KIRC was identified, primarily involved in ion transport.
- SLC9A2 was identified as a downstream target of zDHHC3, with its expression and S-palmitoylation reduced upon zDHHC3 suppression, inhibiting Caki-2 cell apoptosis.
Conclusions:
- zDHHC3 plays a crucial role in KIRC, partly through regulating SLC9A2 S-palmitoylation.
- The zDHHC3-SLC9A2 axis represents a potential novel therapeutic strategy for KIRC treatment.
More Related Videos
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Caspases